FDA Approves First Non-Sedating Drug for Alzheimer's Agitation

Alzheimer's patients struggling with agitation finally have a gentler treatment option that won't leave them drowsy or harm their hearts.

The FDA just approved Auvelity, offering hope to millions of families navigating one of the disease's most challenging symptoms.